Citadel Advisors
SANA icon

Citadel Advisors’s Sana Biotechnology SANA Stock Holding History

Citadel Advisors’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$215K Sell
74,600
-8,900
-11% -$35.1K ﹤0.01% 11275
2025
Q4 		$340K Sell
83,500
-15,000
-15% -$67.2K ﹤0.01% 9873
2025
Q3 		$350K Buy
98,500
+47,400
+93% +$171K ﹤0.01% 10005
2025
Q2 		$140K Sell
51,100
-36,200
-41% -$74.7K ﹤0.01% 11025
2025
Q1 		$147K Buy
87,300
+78,100
+849% +$218K ﹤0.01% 10911
2024
Q4 		$15K Sell
9,200
-3,100
-25% -$9.24K ﹤0.01% 13379
2024
Q3 		$51.2K Sell
12,300
-115,100
-90% -$605K ﹤0.01% 11888
2024
Q2 		$696K Buy
127,400
+96,500
+312% +$769K ﹤0.01% 7371
2024
Q1 		$309K Buy
30,900
+30,000
+3,333% +$225K ﹤0.01% 9390
2023
Q4 		$3.67K Sell
900
-7,200
-89% -$26.5K ﹤0.01% 13570
2023
Q3 		$31.3K Buy
8,100
+6,900
+575% +$37.1K ﹤0.01% 12231
2023
Q2 		$7.15K Sell
1,200
-8,600
-88% -$49.6K ﹤0.01% 13386
2023
Q1 		$32K Buy
9,800
+4,000
+69% +$16K ﹤0.01% 12659
2022
Q4 		$22.9K Sell
5,800
-4,200
-42% -$20.5K ﹤0.01% 13032
2022
Q3 		$60K Buy
+10,000
New +$72.2K ﹤0.01% 11501
2022
Q1 		– Sell
-19,700
Closed -$305K – 14454
2021
Q4 		$305K Buy
19,700
+6,500
+49% +$125K ﹤0.01% 10883
2021
Q3 		$297K Buy
+13,200
New +$277K ﹤0.01% 11086

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Citadel Advisors's SANA Position: Q1 2026 in Review

Citadel Advisors increased its Sana Biotechnology (SANA) stake by 4,103% in Q1 2026, buying an estimated $2.19M and bringing the position to 569,090 shares worth $1.64M. The position accounts for ﹤0.01% of the portfolio, ranked #6533.

Citadel Advisors first reported a position in SANA in Q1 2021 and has held it in 20 quarters since. The position peaked at $23.3M in Q3 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Citadel Advisors held 569,090 shares of Sana Biotechnology worth $1.64M as of Q1 2026.
  • Citadel Advisors bought 555,549 Sana Biotechnology shares in Q1 2026, an estimated $2.19M.
  • Sana Biotechnology made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6533 holding.
  • Citadel Advisors first reported a position in Sana Biotechnology in Q1 2021 and has held it in 20 quarters since.
  • Citadel Advisors's Sana Biotechnology position peaked at $23.3M in Q3 2025.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.